Undifferentiated Pleomorphic Sarcoma Can respond to checkpoint blockade like pembrolizumab

Seth M. Pollack, MD, Fred Hutchinson Cancer Research Center, explains Undifferentiated Pleomorphic Sarcoma Can respond to checkpoint blockade like pembrolizumab at ASCO 2018 Author: Annual-Meeting Added: 06/05/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts